U.S. Physical Therapy Stock Price, News & Analysis (NYSE:USPH)

$68.85 0.35 (0.51 %)
(As of 11/17/2017 04:00 PM ET)
Previous Close$68.85
Today's Range$67.95 - $69.00
52-Week Range$56.50 - $78.00
Volume39,446 shs
Average Volume67,148 shs
Market Capitalization$870.64 million
P/E Ratio32.83
Dividend Yield1.16%
Beta1.07

About U.S. Physical Therapy (NYSE:USPH)

U.S. Physical Therapy logoU.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. The Company's segment is made up of various clinics within partnerships. The Company primarily operates through subsidiary clinic partnerships, in which it owns a general partnership interest and a limited partnership interest, and the managing therapists of the clinics owns the remaining limited partnership interest in the clinics. The Company operates 562 physical therapy clinics in 42 states. There are approximately 380 clinics operated under Clinic Partnerships and over 100 operated as Company-owned Facilities. In addition to its owned clinics, it also manages physical therapy facilities for third parties, primarily physicians, with over 29 third-party facilities under management.


Industry, Sector and Symbol:
  • Industry: Hospitals, Clinics & Primary Care Services
  • Sub-Industry: Health Care Facilities
  • Sector: Hospitals, Clinics & Primary Care Services
  • Symbol: NYSE:USPH
  • CUSIP: 90337L10
  • Web: corporate.usph.com
Debt:
  • Debt-to-Equity Ratio: 0.30%
  • Current Ratio: 2.04%
  • Quick Ratio: 2.04%
Price-To-Earnings:
  • Trailing P/E Ratio: 32.83
  • Forward P/E Ratio: 33.26
  • P/E Growth: 2.92
Sales & Book Value:
  • Annual Sales: $356.55 million
  • Price / Sales: 2.43
  • Cash Flow: $2.68 per share
  • Price / Cash: 25.73
  • Book Value: $15.89 per share
  • Price / Book: 4.33
Dividend:
  • Annual Dividend: $0.80
  • Dividend Yield: 1.2%
Profitability:
  • Trailing EPS: $1.38
  • Net Income: $20.55 million
  • Net Margins: 5.29%
  • Return on Equity: 13.37%
  • Return on Assets: 6.63%
Misc:
  • Employees: 3,800
  • Outstanding Shares: 12,580,000
 

Frequently Asked Questions for U.S. Physical Therapy (NYSE:USPH)

What is U.S. Physical Therapy's stock symbol?

U.S. Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "USPH."

How often does U.S. Physical Therapy pay dividends? What is the dividend yield for U.S. Physical Therapy?

U.S. Physical Therapy announced a quarterly dividend on Tuesday, October 31st. Shareholders of record on Friday, November 17th will be paid a dividend of $0.20 per share on Friday, December 8th. This represents a $0.80 annualized dividend and a dividend yield of 1.16%. The ex-dividend date is Thursday, November 16th. View U.S. Physical Therapy's Dividend History.

How were U.S. Physical Therapy's earnings last quarter?

U.S. Physical Therapy, Inc. (NYSE:USPH) issued its earnings results on Thursday, November, 2nd. The company reported $0.48 earnings per share for the quarter, missing the Zacks' consensus estimate of $0.52 by $0.04. The firm had revenue of $103.03 million for the quarter, compared to the consensus estimate of $102.69 million. U.S. Physical Therapy had a net margin of 5.29% and a return on equity of 13.37%. View U.S. Physical Therapy's Earnings History.

Where is U.S. Physical Therapy's stock going? Where will U.S. Physical Therapy's stock price be in 2017?

4 brokers have issued twelve-month price targets for U.S. Physical Therapy's shares. Their forecasts range from $65.00 to $74.00. On average, they expect U.S. Physical Therapy's stock price to reach $70.25 in the next year. View Analyst Ratings for U.S. Physical Therapy.

What are Wall Street analysts saying about U.S. Physical Therapy stock?

Here are some recent quotes from research analysts about U.S. Physical Therapy stock:

  • 1. Cantor Fitzgerald analysts commented, "Storm impact contained, outlook fine. Hurricanes cost an estimated $0.03 per share in 3Q17, fully diluted EPS were $0.48 (vs. our $0.52 estimate), and we are reducing our full year 2017 estimate to $2.10 (from $2.15). We are raising our 2018 estimate to $2.45 (from $2.40). Our corresponding full year adjusted EBITDA estimates (3Q17 results were about $900,000 shy of our $14.6 million estimate) are $57.7 million for 2017 (vs. prior $58.6 million) and $65.5 million (vs. prior $63.7 million ) for 2018. Commercial reimbursement rates look fine for 2018; the average reimbursement for commercial is $100 vs. Medicare’s $90." (11/2/2017)
  • 2. According to Zacks Investment Research, "U.S. Physical Therapy, Inc. operates outpatient physical and occupational therapy clinics which provide post-operative care and treatment for a variety of orthopedic-related disorders and sports-related injuries. " (10/7/2017)

Who are some of U.S. Physical Therapy's key competitors?

Who are U.S. Physical Therapy's key executives?

U.S. Physical Therapy's management team includes the folowing people:

  • Jerald L. Pullins, Independent Chairman of the Board (Age 75)
  • Christopher J. Reading, President, Chief Executive Officer, Director (Age 53)
  • Lawrance W. McAfee, Chief Financial Officer, Executive Vice President, Director (Age 62)
  • Glenn D. McDowell, Chief Operating Officer (Age 60)
  • Reginald E. Swanson, Director (Age 63)
  • Mark J. Brookner, Independent Director (Age 72)
  • Harry S. Chapman, Independent Director (Age 72)
  • Bernard A. Harris Jr., Independent Director (Age 60)
  • Edward L. Kuntz, Independent Director (Age 72)

Who owns U.S. Physical Therapy stock?

U.S. Physical Therapy's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Neuberger Berman Group LLC (8.26%), Dimensional Fund Advisors LP (3.93%), Riverbridge Partners LLC (2.74%), Royce & Associates LP (2.47%), Bank of New York Mellon Corp (1.44%) and Thomson Horstmann & Bryant Inc. (0.97%). Company insiders that own U.S. Physical Therapy stock include Bernard A Harris Jr, Christopher J Reading, Clayton Trier, Edward L Kuntz, Glenn Mcdowell, Jerald L Pullins, Lawrance W Mcafee and Regg E Swanson. View Institutional Ownership Trends for U.S. Physical Therapy.

Who sold U.S. Physical Therapy stock? Who is selling U.S. Physical Therapy stock?

U.S. Physical Therapy's stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Neuberger Berman Group LLC, Russell Investments Group Ltd., Thomson Horstmann & Bryant Inc., Ameriprise Financial Inc., Albert D Mason Inc., Royce & Associates LP and Bank of New York Mellon Corp. Company insiders that have sold U.S. Physical Therapy company stock in the last year include Bernard A Harris Jr, Christopher J Reading, Edward L Kuntz, Glenn Mcdowell and Lawrance W Mcafee. View Insider Buying and Selling for U.S. Physical Therapy.

Who bought U.S. Physical Therapy stock? Who is buying U.S. Physical Therapy stock?

U.S. Physical Therapy's stock was acquired by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, OxFORD Asset Management LLP, King Luther Capital Management Corp, Citadel Advisors LLC, Algert Global LLC, JPMorgan Chase & Co., Cadence Capital Management LLC and Dimensional Fund Advisors LP. View Insider Buying and Selling for U.S. Physical Therapy.

How do I buy U.S. Physical Therapy stock?

Shares of U.S. Physical Therapy can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is U.S. Physical Therapy's stock price today?

One share of U.S. Physical Therapy stock can currently be purchased for approximately $68.85.

How big of a company is U.S. Physical Therapy?

U.S. Physical Therapy has a market capitalization of $870.64 million and generates $356.55 million in revenue each year. The company earns $20.55 million in net income (profit) each year or $1.38 on an earnings per share basis. U.S. Physical Therapy employs 3,800 workers across the globe.

How can I contact U.S. Physical Therapy?

U.S. Physical Therapy's mailing address is 1300 W Sam Houston Pkwy N Ste 300, HOUSTON, TX 77043-4011, United States. The company can be reached via phone at +1-713-2977000 or via email at [email protected]


MarketBeat Community Rating for U.S. Physical Therapy (NYSE USPH)

Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  117 (Vote Outperform)
Underperform Votes:  202 (Vote Underperform)
Total Votes:  319
MarketBeat's community ratings are surveys of what our community members think about U.S. Physical Therapy and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for U.S. Physical Therapy (NYSE:USPH)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 2 Hold Ratings, 2 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $70.25 (2.03% upside)

Consensus Price Target History for U.S. Physical Therapy (NYSE:USPH)

Price Target History for U.S. Physical Therapy (NYSE:USPH)

Analysts' Ratings History for U.S. Physical Therapy (NYSE:USPH)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/3/2017Barrington ResearchDowngradeOutperform -> Market PerformN/AView Rating Details
11/2/2017Cantor FitzgeraldReiterated RatingBuy$74.00N/AView Rating Details
9/8/2017SidotiUpgradeNeutral -> Buy$62.00 -> $74.00LowView Rating Details
8/4/2017Jefferies Group LLCSet Price TargetHold$65.00LowView Rating Details
11/7/2016JMP SecuritiesReiterated RatingHoldN/AView Rating Details
(Data available from 11/18/2015 forward)

Earnings

Earnings History and Estimates Chart for U.S. Physical Therapy (NYSE:USPH)

Earnings by Quarter for U.S. Physical Therapy (NYSE:USPH)

Earnings History by Quarter for U.S. Physical Therapy (NYSE USPH)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/2/2017Q3 2017$0.52$0.48$102.69 million$103.03 millionViewN/AView Earnings Details
8/3/2017Q2 2017$0.60$0.59$102.93 million$104.25 millionViewListenView Earnings Details
6/29/2017Q1 2017$0.49$0.51$97.60 million$97.57 millionViewN/AView Earnings Details
11/3/2016Q316$0.49$0.46$33.94 million$88.30 millionViewN/AView Earnings Details
8/4/2016Q216$0.55$0.57$90.01 million$90.40 millionViewN/AView Earnings Details
5/5/2016Q116$0.39$0.43$83.35 million$86.90 millionViewN/AView Earnings Details
3/3/2016Q4$0.47$0.48$85.47 million$86.72 millionViewN/AView Earnings Details
11/5/2015Q315$0.48$0.47$84.07 million$84.00 millionViewN/AView Earnings Details
8/6/2015Q215$0.58$0.51$84.24 million$83.30 millionViewN/AView Earnings Details
5/7/2015Q115$0.35$0.34$74.74 million$77.24 millionViewN/AView Earnings Details
3/5/2015$0.39$0.41$75.29 million$79.39 millionViewN/AView Earnings Details
11/6/2014Q314$0.42$0.43$75.50 million$77.70 millionViewN/AView Earnings Details
8/7/2014Q214$0.44$0.52$74.25 million$66.90 millionViewN/AView Earnings Details
5/8/2014Q114$0.30$0.35$67.70 million$62.80 millionViewN/AView Earnings Details
3/6/2014Q413$0.35$0.32$65.33 million$62.38 millionViewN/AView Earnings Details
11/7/2013Q313$0.40$0.38$66.32 million$65.83 millionViewN/AView Earnings Details
8/8/2013Q2 2013$0.42$0.41$66.49 million$67.22 millionViewN/AView Earnings Details
5/9/2013Q1 2013$0.33$0.31$62.26 million$63.10 millionViewN/AView Earnings Details
3/7/2013Q4 2012$0.33$0.34$61.99 million$62.70 millionViewN/AView Earnings Details
11/8/2012Q312$0.38$0.38$63.77 million$62.80 millionViewN/AView Earnings Details
8/9/2012$0.44$0.41ViewN/AView Earnings Details
5/3/2012$0.34$0.38ViewN/AView Earnings Details
3/8/2012$0.28$0.29ViewN/AView Earnings Details
11/3/2011$0.35$0.34ViewN/AView Earnings Details
8/4/2011$0.41$0.41ViewN/AView Earnings Details
5/5/2011$0.27$0.31ViewN/AView Earnings Details
3/3/2011$0.25$0.28ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for U.S. Physical Therapy (NYSE:USPH)
Current Year EPS Consensus Estimate: $2.07 EPS
Next Year EPS Consensus Estimate: $2.41 EPS

Dividends

Current Dividend Information for U.S. Physical Therapy (NYSE:USPH)

Next Dividend:12/8/2017
Annual Dividend:$0.80
Dividend Yield:1.16%
Dividend Growth:19.30% (3 Year Average)
Payout Ratio:57.97% (Trailing 12 Months of Earnings)
38.65% (Based on This Year's Estimates)
33.20% (Based on Next Year's Estimates)
Track Record:6 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for U.S. Physical Therapy (NYSE:USPH)

Dividend History by Quarter for U.S. Physical Therapy (NYSE USPH)

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/31/2017Quarterly$0.201.21%11/16/201711/17/201712/8/2017
8/3/2017quarterly$0.201.27%8/17/20178/21/20179/8/2017
5/31/2017Quarterly$0.201.25%6/14/20176/16/20177/7/2017
4/3/2017quarterly$0.201.25%4/12/20174/17/20175/5/2017
11/3/2016quarterly$0.171.28%11/16/201611/18/201612/2/2016
8/4/2016quarterly$0.171.12%8/17/20168/19/20169/2/2016
5/5/2016quarterly$0.171.31%5/13/20165/17/20166/3/2016
3/4/2016quarterly$0.171.33%3/16/20163/18/20164/1/2016
11/6/2015quarterly$0.151.15%11/13/201511/17/201512/4/2015
8/7/2015quarterly$0.151.18%8/14/20158/18/20159/4/2015
5/7/2015quarterly$0.151.24%5/14/20155/18/20156/5/2015
3/6/2015quarterly$0.151.33%3/18/20153/20/20154/3/2015
11/6/2014quarterly$0.121.23%11/13/201411/17/201412/5/2014
8/7/2014quarterly$0.121.32%8/14/20148/18/20149/5/2014
5/8/2014quarterly$0.121.54%5/16/20145/20/20146/6/2014
3/7/2014quarterly$0.121.48%3/17/20143/19/20144/4/2014
11/7/2013quarterly$0.101.36%11/13/201311/15/201312/6/2013
8/8/2013quarterly$0.101.28%8/16/20138/20/20139/6/2013
5/9/2013quarterly$0.101.59%5/15/20135/17/20136/7/2013
3/7/2013quarterly$0.101.71%3/13/20133/15/20133/29/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for U.S. Physical Therapy (NYSE USPH)

Insider Ownership Percentage: 3.10%
Institutional Ownership Percentage: 93.96%
Insider Trades by Quarter for U.S. Physical Therapy (NYSE:USPH)
Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Insider Trades by Quarter for U.S. Physical Therapy (NYSE USPH)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/16/2017Lawrance W. McafeeCFOSell2,000$68.68$137,360.00View SEC Filing  
11/8/2017Christopher J. ReadingCEOSell15,000$66.52$997,800.00View SEC Filing  
11/8/2017Lawrance W. McafeeCFOSell5,200$66.37$345,124.00View SEC Filing  
11/3/2017Lawrance W. McafeeCFOSell800$69.21$55,368.00View SEC Filing  
8/30/2017Glenn McdowellCOOSell2,598$57.00$148,086.00View SEC Filing  
8/29/2017Glenn McdowellCOOSell1,004$57.01$57,238.04View SEC Filing  
8/22/2017Glenn McdowellCOOSell1,664$59.91$99,690.24View SEC Filing  
8/11/2017Lawrance W. McafeeCFOSell3,000$62.04$186,120.00View SEC Filing  
8/10/2017Bernard A Harris JrDirectorSell5,000$62.00$310,000.00View SEC Filing  
12/9/2016Edward L. KuntzDirectorSell2,500$68.40$171,000.00View SEC Filing  
11/22/2016Lawrance W. McafeeCFOSell2,000$62.55$125,100.00View SEC Filing  
11/15/2016Glenn McdowellCOOSell4,047$61.15$247,474.05View SEC Filing  
11/10/2016Lawrance W. McafeeCFOSell2,000$58.04$116,080.00View SEC Filing  
9/19/2016Christopher J. ReadingCEOSell8,000$64.01$512,080.00View SEC Filing  
9/19/2016Lawrance W. McafeeCFOSell2,000$64.00$128,000.00View SEC Filing  
8/25/2016Lawrance W. McafeeCFOSell2,000$62.50$125,000.00View SEC Filing  
8/9/2016Glenn McdowellCOOSell4,047$60.20$243,629.40View SEC Filing  
8/5/2016Lawrance W. McafeeCFOSell2,000$59.60$119,200.00View SEC Filing  
6/10/2016Lawrance W McafeeCFOSell2,000$59.27$118,540.00View SEC Filing  
5/20/2016Regg E SwansonDirectorSell3,000$57.29$171,870.00View SEC Filing  
5/11/2016Bernard A Harris JrDirectorSell3,000$58.10$174,300.00View SEC Filing  
5/9/2016Glenn McdowellCOOSell8,354$57.95$484,114.30View SEC Filing  
5/9/2016Lawrance W McafeeCFOSell4,000$54.90$219,600.00View SEC Filing  
3/14/2016Jerald L PullinsDirectorSell5,000$51.35$256,750.00View SEC Filing  
3/4/2016Lawrance W McafeeCFOSell5,000$52.74$263,700.00View SEC Filing  
12/29/2015Clayton TrierDirectorSell4,500$55.23$248,535.00View SEC Filing  
12/16/2015Lawrance W McafeeCFOSell4,000$51.24$204,960.00View SEC Filing  
11/20/2015Christopher J. ReadingCEOSell25,000$52.12$1,303,000.00View SEC Filing  
11/11/2015Glenn McdowellCOOSell4,299$51.25$220,323.75View SEC Filing  
11/6/2015Lawrance W McafeeCFOSell4,000$51.00$204,000.00View SEC Filing  
8/25/2015Lawrance W McafeeCFOSell2,000$47.06$94,120.00View SEC Filing  
8/24/2015Harry S ChapmanDirectorBuy1,000$46.90$46,900.00View SEC Filing  
8/18/2015Regg E SwansonDirectorSell2,000$51.68$103,360.00View SEC Filing  
3/20/2015Lawrance W McafeeCFOSell2,350$48.25$113,387.50View SEC Filing  
3/19/2015Christopher J ReadingCEOSell22,600$48.12$1,087,512.00View SEC Filing  
3/17/2015Glenn McdowellCOOSell2,299$47.92$110,168.08View SEC Filing  
3/16/2015Christopher J ReadingCEOSell2,400$49.29$118,296.00View SEC Filing  
3/16/2015Glenn McdowellCOOSell2,000$49.13$98,260.00View SEC Filing  
3/16/2015Lawrance W McafeeCFOSell2,650$49.07$130,035.50View SEC Filing  
3/9/2015Clayton TrierDirectorSell3,250$45.05$146,412.50View SEC Filing  
3/6/2015Lawrance W McafeeCFOSell10,000$45.34$453,400.00View SEC Filing  
12/5/2014Glenn McdowellCOOSell19,621$39.95$783,858.95View SEC Filing  
12/2/2014Clayton TrierDirectorSell3,250$39.49$128,342.50View SEC Filing  
11/28/2014Christopher J ReadingCEOSell9,759$39.29$383,431.11View SEC Filing  
11/25/2014Christopher J ReadingCEOSell10,241$39.00$399,399.00View SEC Filing  
11/11/2014Clayton TrierDirectorSell1,002$39.83$39,909.66View SEC Filing  
11/7/2014Lawrance W McafeeCFOSell10,000$39.23$392,300.00View SEC Filing  
9/5/2014Mark J BrooknerDirectorSell3,105$35.80$111,159.00View SEC Filing  
9/3/2014Mark J BrooknerDirectorSell549$35.82$19,665.18View SEC Filing  
9/2/2014Jerald L PullinsDirectorSell3,000$35.46$106,380.00View SEC Filing  
8/29/2014Mark J BrooknerDirectorSell96$35.75$3,432.00View SEC Filing  
8/27/2014Jerald L PullinsDirectorSell3,000$35.86$107,580.00View SEC Filing  
8/8/2014Lawrance W McafeeCFOSell5,000$34.55$172,750.00View SEC Filing  
3/28/2014Jerald PullinsDirectorSell6,000$32.92$197,520.00View SEC Filing  
3/12/2014Jerald PullinsDirectorSell7,000$32.98$230,860.00View SEC Filing  
3/7/2014Lawrance McafeeCFOSell10,000$32.07$320,700.00View SEC Filing  
11/22/2013Lawrance McafeeCFOSell5,000$33.02$165,100.00View SEC Filing  
11/11/2013Harry ChapmanDirectorBuy1,750$30.18$52,815.00View SEC Filing  
11/8/2013Lawrance McafeeCFOSell5,000$29.71$148,550.00View SEC Filing  
9/4/2013Glenn McdowellCOOSell11,148$28.54$318,163.92View SEC Filing  
8/9/2013Lawrance McafeeCFOSell10,000$29.81$298,100.00View SEC Filing  
6/13/2013Christopher J ReadingCEOSell20,000$29.05$581,000.00View SEC Filing  
6/10/2013Lawrance W McafeeCFOSell5,000$29.18$145,900.00View SEC Filing  
5/28/2013Clayton TrierDirectorSell6,500$28.35$184,275.00View SEC Filing  
5/10/2013Lawrance W McafeeCFOSell5,000$24.55$122,750.00View SEC Filing  
12/12/2012Harry S ChapmanDirectorBuy1,200$27.02$32,424.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for U.S. Physical Therapy (NYSE:USPH)

Latest Headlines for U.S. Physical Therapy (NYSE USPH)

Source:
DateHeadline
U.S. Physical Therapy (USPH) versus Its Competitors Head-To-Head AnalysisU.S. Physical Therapy (USPH) versus Its Competitors Head-To-Head Analysis
www.americanbankingnews.com - November 18 at 3:37 AM
Lawrance W. Mcafee Sells 2,000 Shares of U.S. Physical Therapy, Inc. (USPH) StockLawrance W. Mcafee Sells 2,000 Shares of U.S. Physical Therapy, Inc. (USPH) Stock
www.americanbankingnews.com - November 17 at 1:48 PM
U.S. Physical Therapy, Inc. (USPH) Expected to Post Quarterly Sales of $105.83 MillionU.S. Physical Therapy, Inc. (USPH) Expected to Post Quarterly Sales of $105.83 Million
www.americanbankingnews.com - November 14 at 3:10 AM
U.S. Physical Therapy renews $125M credit lineU.S. Physical Therapy renews $125M credit line
seekingalpha.com - November 12 at 1:01 PM
U.S. Physical Therapy, Inc. (USPH) Plans $0.20 Quarterly DividendU.S. Physical Therapy, Inc. (USPH) Plans $0.20 Quarterly Dividend
www.americanbankingnews.com - November 11 at 10:22 AM
U.S. Physical Therapy, Inc. (USPH) CEO Christopher J. Reading Sells 15,000 SharesU.S. Physical Therapy, Inc. (USPH) CEO Christopher J. Reading Sells 15,000 Shares
www.americanbankingnews.com - November 9 at 3:30 PM
U.S. Physical Therapy, Inc. (USPH) CFO Lawrance W. Mcafee Sells 5,200 SharesU.S. Physical Therapy, Inc. (USPH) CFO Lawrance W. Mcafee Sells 5,200 Shares
www.americanbankingnews.com - November 9 at 3:28 PM
Reviewing <html id= (VHS) and U.S. Physical Therapy (USPH)Reviewing
www.americanbankingnews.com - November 8 at 9:31 AM
Insider Selling: U.S. Physical Therapy, Inc. (USPH) CFO Sells 800 Shares of StockInsider Selling: U.S. Physical Therapy, Inc. (USPH) CFO Sells 800 Shares of Stock
www.americanbankingnews.com - November 7 at 3:36 PM
U.S. Physical Therapy, Inc. (USPH) Lowered to Market Perform at Barrington ResearchU.S. Physical Therapy, Inc. (USPH) Lowered to Market Perform at Barrington Research
www.americanbankingnews.com - November 5 at 4:56 PM
Edited Transcript of USPH earnings conference call or presentation 2-Nov-17 2:30pm GMTEdited Transcript of USPH earnings conference call or presentation 2-Nov-17 2:30pm GMT
finance.yahoo.com - November 5 at 8:07 AM
U.S. Physical Therapy, Inc. (USPH) Issues  Earnings Results, Misses Expectations By $0.04 EPSU.S. Physical Therapy, Inc. (USPH) Issues Earnings Results, Misses Expectations By $0.04 EPS
www.americanbankingnews.com - November 3 at 7:48 PM
U.S. Physical Therapy, Inc. (USPH) Earns "Buy" Rating from Cantor FitzgeraldU.S. Physical Therapy, Inc. (USPH) Earns "Buy" Rating from Cantor Fitzgerald
www.americanbankingnews.com - November 2 at 3:56 PM
U.S. Physical Therapy takes majority stake in nine-clinic practice for $4.5MU.S. Physical Therapy takes majority stake in nine-clinic practice for $4.5M
seekingalpha.com - November 2 at 10:41 AM
U.S. Physical Therapy to Present at the Stephens Fall Investment ConferenceU.S. Physical Therapy to Present at the Stephens Fall Investment Conference
finance.yahoo.com - November 2 at 10:41 AM
U.S. Physical Therapy Reports Third Quarter and Nine Months 2017 ResultsU.S. Physical Therapy Reports Third Quarter and Nine Months 2017 Results
finance.yahoo.com - November 2 at 10:41 AM
U.S. Physical Therapy, Inc. to Host Earnings CallU.S. Physical Therapy, Inc. to Host Earnings Call
finance.yahoo.com - November 2 at 10:40 AM
U.S. Physical Therapy misses 3Q profit forecastsU.S. Physical Therapy misses 3Q profit forecasts
finance.yahoo.com - November 2 at 10:40 AM
U.S. Physical Therapy, Inc. (USPH) Given Average Rating of "Hold" by BrokeragesU.S. Physical Therapy, Inc. (USPH) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - November 1 at 3:22 PM
U.S. Physical Therapy Announces Another AcquisitionU.S. Physical Therapy Announces Another Acquisition
finance.yahoo.com - November 1 at 10:14 AM
ETFs with exposure to U.S. Physical Therapy, Inc. : October 27, 2017ETFs with exposure to U.S. Physical Therapy, Inc. : October 27, 2017
finance.yahoo.com - October 28 at 5:53 PM
U.S. Physical Therapy Reaches Analyst Target PriceU.S. Physical Therapy Reaches Analyst Target Price
www.thestreet.com - October 24 at 4:02 PM
U.S. Physical Therapy, Inc. Schedules Third Quarter 2017 Release and Conference Call for Thursday, November 2, 2017U.S. Physical Therapy, Inc. Schedules Third Quarter 2017 Release and Conference Call for Thursday, November 2, 2017
finance.yahoo.com - October 17 at 8:39 AM
Janssen Announces U.S. FDA Approval Of STELARA® (ustekinumab) For The Treatment Of Adolescents With Moderate To Severe Plaque PsoriasisJanssen Announces U.S. FDA Approval Of STELARA® (ustekinumab) For The Treatment Of Adolescents With Moderate To Severe Plaque Psoriasis
finance.yahoo.com - October 15 at 8:01 AM
ETFs with exposure to U.S. Physical Therapy, Inc. : October 13, 2017ETFs with exposure to U.S. Physical Therapy, Inc. : October 13, 2017
finance.yahoo.com - October 14 at 9:02 AM
U.S. Physical Therapy, Inc. (USPH) Receives Average Recommendation of "Hold" from AnalystsU.S. Physical Therapy, Inc. (USPH) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - October 7 at 4:34 PM
Zacks Investment Research Downgrades U.S. Physical Therapy, Inc. (USPH) to SellZacks Investment Research Downgrades U.S. Physical Therapy, Inc. (USPH) to Sell
www.americanbankingnews.com - October 7 at 6:36 AM
U.S. Physical Therapy Announces Impact to Operations from Hurricanes Harvey and IrmaU.S. Physical Therapy Announces Impact to Operations from Hurricanes Harvey and Irma
finance.yahoo.com - October 3 at 2:23 PM
U.S. Physical Therapy, Inc. breached its 50 day moving average in a Bullish Manner : USPH-US : September 28, 2017U.S. Physical Therapy, Inc. breached its 50 day moving average in a Bullish Manner : USPH-US : September 28, 2017
finance.yahoo.com - October 3 at 2:23 PM
U.S. Physical Therapy, Inc. :USPH-US: Earnings Analysis: Q2, 2017 By the Numbers : September 29, 2017U.S. Physical Therapy, Inc. :USPH-US: Earnings Analysis: Q2, 2017 By the Numbers : September 29, 2017
finance.yahoo.com - October 3 at 2:23 PM
ETFs with exposure to U.S. Physical Therapy, Inc. : October 2, 2017ETFs with exposure to U.S. Physical Therapy, Inc. : October 2, 2017
finance.yahoo.com - October 3 at 2:23 PM
U.S. Physical Therapys (USPH) Buy Rating Reiterated at Cantor FitzgeraldU.S. Physical Therapy's (USPH) Buy Rating Reiterated at Cantor Fitzgerald
www.americanbankingnews.com - September 26 at 9:32 AM
U.S. Physical Therapy to Present at the 2017 Cantor Fitzgerald Global Healthcare ConferenceU.S. Physical Therapy to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference
finance.yahoo.com - September 23 at 10:39 AM
U.S. Physical Therapy, Inc. (USPH) Expected to Post Quarterly Sales of $102.69 MillionU.S. Physical Therapy, Inc. (USPH) Expected to Post Quarterly Sales of $102.69 Million
www.americanbankingnews.com - September 18 at 9:01 AM
Comparing U.S. Physical Therapy (USPH) and Premier (PINC)Comparing U.S. Physical Therapy (USPH) and Premier (PINC)
www.americanbankingnews.com - September 13 at 6:44 PM
U.S. Physical Therapy, Inc. (USPH) Receives Consensus Recommendation of "Hold" from AnalystsU.S. Physical Therapy, Inc. (USPH) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - September 12 at 6:46 PM
U.S. Physical Therapy to Present at the 2017 Credit Suisse Under Followed Opportunities ConferenceU.S. Physical Therapy to Present at the 2017 Credit Suisse Under Followed Opportunities Conference
finance.yahoo.com - September 12 at 11:42 AM
U.S. Physical Therapy, Inc. (USPH) Upgraded to Buy at SidotiU.S. Physical Therapy, Inc. (USPH) Upgraded to Buy at Sidoti
www.americanbankingnews.com - September 8 at 9:28 AM
Insider Selling: U.S. Physical Therapy, Inc. (USPH) COO Sells 1,004 Shares of StockInsider Selling: U.S. Physical Therapy, Inc. (USPH) COO Sells 1,004 Shares of Stock
www.americanbankingnews.com - September 1 at 8:32 PM
U.S. Physical Therapy, Inc. (USPH) COO Sells $148,086.00 in StockU.S. Physical Therapy, Inc. (USPH) COO Sells $148,086.00 in Stock
www.americanbankingnews.com - September 1 at 8:04 PM
$0.54 EPS Expected for U.S. Physical Therapy, Inc. (USPH) This Quarter$0.54 EPS Expected for U.S. Physical Therapy, Inc. (USPH) This Quarter
www.americanbankingnews.com - August 28 at 8:08 PM
U.S. Physical Therapy, Inc. (USPH) COO Sells $99,690.24 in StockU.S. Physical Therapy, Inc. (USPH) COO Sells $99,690.24 in Stock
www.americanbankingnews.com - August 23 at 4:20 PM
Head to Head Analysis: U.S. Physical Therapy (USPH) & AAC Holdings (AAC)Head to Head Analysis: U.S. Physical Therapy (USPH) & AAC Holdings (AAC)
www.americanbankingnews.com - August 20 at 4:22 AM
U.S. Physical Therapy, Inc. (USPH) Receives Average Rating of "Hold" from BrokeragesU.S. Physical Therapy, Inc. (USPH) Receives Average Rating of "Hold" from Brokerages
www.americanbankingnews.com - August 18 at 6:52 PM
U.S. Physical Therapy goes ex-dividend tomorrowU.S. Physical Therapy goes ex-dividend tomorrow
seekingalpha.com - August 18 at 8:24 AM
Insider Selling: U.S. Physical Therapy, Inc. (NYSE:USPH) CFO Sells 3,000 Shares of StockInsider Selling: U.S. Physical Therapy, Inc. (NYSE:USPH) CFO Sells 3,000 Shares of Stock
www.americanbankingnews.com - August 14 at 1:27 PM
U.S. Physical Therapy (USPH) versus AAC Holdings (AAC) Head-To-Head ReviewU.S. Physical Therapy (USPH) versus AAC Holdings (AAC) Head-To-Head Review
www.americanbankingnews.com - August 12 at 10:08 PM
 Brokerages Anticipate U.S. Physical Therapy, Inc. (NYSE:USPH) Will Announce Quarterly Sales of $102.69 Million Brokerages Anticipate U.S. Physical Therapy, Inc. (NYSE:USPH) Will Announce Quarterly Sales of $102.69 Million
www.americanbankingnews.com - August 12 at 10:38 AM
U.S. Physical Therapy, Inc. (USPH) Director Bernard A. Harris, Jr. Sells 5,000 SharesU.S. Physical Therapy, Inc. (USPH) Director Bernard A. Harris, Jr. Sells 5,000 Shares
www.americanbankingnews.com - August 11 at 1:22 PM
U.S. Physical Therapy, Inc. breached its 50 day moving average in a Bullish Manner : USPH-US : August 7, 2017U.S. Physical Therapy, Inc. breached its 50 day moving average in a Bullish Manner : USPH-US : August 7, 2017
finance.yahoo.com - August 8 at 8:00 AM

Social Media

Financials

Chart

U.S. Physical Therapy (NYSE USPH) Chart for Saturday, November, 18, 2017
Loading chart…

This page was last updated on 11/18/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.